Daniel A. Rushing, MD
Professor Emeritus of Clinical Medicine
- Phone
- 317-948-7576
- Address
-
535 Barnhill Drive
Suite 473
RT 473
Indianapolis, IN 46202-5289 - PubMed:
-
Link to PubMed
| Year | Degree | Institution |
|---|---|---|
| 1981 | Fellowship | University of Minnesota, Minneapolis, MN |
| 1979 | Residency | Rush-Presbyterian St. Luke's Medical Center, Chicago, IL |
| 1976 | MD | University of Illinois |
| 1972 | BA | Indiana University |
A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Regorafenib vs. Placebo in Advanced/Metastatic, Treatment-Refractory Liposarcoma; Results from the SARC024 Study.
Riedel, RF; Ballman, KV; Lu, Y; Attia, S; Loggers, ET; Ganjoo, KN; Livingston, MB; Chow, WA; Wright, JA; Ward, JH; Rushing, DA; Okuno, SH; Reed, DR; Liebner, DA; Keedy, VL; Mascarenhas, L; Davis, LE; Ryan, CQ; Reinke, DK; Maki, RG Proceedings of the American Society of Clinical Oncology May 2018
Riedel, RF; Ballman, KV; Lu, Y; Attia, S; Loggers, ET; Ganjoo, KN; Livingston, MB; Chow, WA; Wright, JA; Ward, JH; Rushing, DA; Okuno, SH; Reed, DR; Liebner, DA; Keedy, VL; Mascarenhas, L; Davis, LE; Ryan, CQ; Reinke, DK; Maki, RG Proceedings of the American Society of Clinical Oncology May 2018
Overall survival and histology-specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma.
Patel S; von Mehren M; Reed DR; Kaiser P; Charlson J; Ryan CW; Rushing D; Livingston M; Singh A; Seth R; Forscher C; D'Amato G; Chawla SP; McCarthy S; Wang G; Parekh T; Knoblauch R; Hensley ML; Maki RG; Demetri GD; Cancer 2019 Jun 7
Patel S; von Mehren M; Reed DR; Kaiser P; Charlson J; Ryan CW; Rushing D; Livingston M; Singh A; Seth R; Forscher C; D'Amato G; Chawla SP; McCarthy S; Wang G; Parekh T; Knoblauch R; Hensley ML; Maki RG; Demetri GD; Cancer 2019 Jun 7
Pharmacokinetics of doxorubicin following concomitant intravenous administration of olaratumab (IMC-3G3) to patients with advanced soft tissue sarcoma.
Villalobos VM; Mo G; Agulnik M; Pollack SM; Rushing DA; Singh A; Van Tine BA; McNaughton R; Decker RL; Zhang W; Shahir A; Cronier DM; Cancer medicine 2019 Dec 10
Villalobos VM; Mo G; Agulnik M; Pollack SM; Rushing DA; Singh A; Van Tine BA; McNaughton R; Decker RL; Zhang W; Shahir A; Cronier DM; Cancer medicine 2019 Dec 10
Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma.
Davis LE; Bolejack V; Ryan CW; Ganjoo KN; Loggers ET; Chawla S; Agulnik M; Livingston MB; Reed D; Keedy V; Rushing D; Okuno S; Reinke DK; Riedel RF; Attia S; Mascarenhas L; Maki RG; Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2019 Apr 23
Davis LE; Bolejack V; Ryan CW; Ganjoo KN; Loggers ET; Chawla S; Agulnik M; Livingston MB; Reed D; Keedy V; Rushing D; Okuno S; Reinke DK; Riedel RF; Attia S; Mascarenhas L; Maki RG; Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2019 Apr 23
Association of Dasatinib With Progression-Free Survival Among Patients With Advanced Gastrointestinal Stromal Tumors Resistant to Imatinib.
Schuetze SM; Bolejack V; Thomas DG; von Mehren M; Patel S; Samuels B; Choy E; D'Amato G; Staddon AP; Ganjoo KN; Chow WA; Rushing DA; Forscher CA; Priebat DA; Loeb DM; Chugh R; Okuno S; Reinke DK; Baker LH; JAMA oncology 2018 Jun 1
Schuetze SM; Bolejack V; Thomas DG; von Mehren M; Patel S; Samuels B; Choy E; D'Amato G; Staddon AP; Ganjoo KN; Chow WA; Rushing DA; Forscher CA; Priebat DA; Loeb DM; Chugh R; Okuno S; Reinke DK; Baker LH; JAMA oncology 2018 Jun 1
SARC006: Phase II Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated Chemotherapy-Naive Malignant Peripheral Nerve Sheath Tumors.
Higham CS; Steinberg SM; Dombi E; Perry A; Helman LJ; Schuetze SM; Ludwig JA; Staddon A; Milhem MM; Rushing D; Jones RL; Livingston M; Goldman S; Moertel C; Wagner L; Janhofer D; Annunziata CM; Reinke D; Long L; Viskochil D; Baker L; Widemann BC; Sarcoma 2017 Sep 12
Higham CS; Steinberg SM; Dombi E; Perry A; Helman LJ; Schuetze SM; Ludwig JA; Staddon A; Milhem MM; Rushing D; Jones RL; Livingston M; Goldman S; Moertel C; Wagner L; Janhofer D; Annunziata CM; Reinke D; Long L; Viskochil D; Baker L; Widemann BC; Sarcoma 2017 Sep 12
Efficacy and safety of trabectedin or dacarbazine in patients with advanced uterine leiomyosarcoma after failure of anthracycline-based chemotherapy: Subgroup analysis of a phase 3, randomized clinical trial.
Hensley ML; Patel SR; von Mehren M; Ganjoo K; Jones RL; Staddon A; Rushing D; Milhem M; Monk B; Wang G; McCarthy S; Knoblauch RE; Parekh TV; Maki RG; Demetri GD; Gynecologic oncology 2017 Jun 24
Hensley ML; Patel SR; von Mehren M; Ganjoo K; Jones RL; Staddon A; Rushing D; Milhem M; Monk B; Wang G; McCarthy S; Knoblauch RE; Parekh TV; Maki RG; Demetri GD; Gynecologic oncology 2017 Jun 24
Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor.
Schuetze SM; Bolejack V; Choy E; Ganjoo KN; Staddon AP; Chow WA; Tawbi HA; Samuels BL; Patel SR; von Mehren M; D'Amato G; Leu KM; Loeb DM; Forscher CA; Milhem MM; Rushing DA; Lucas DR; Chugh R; Reinke DK; Baker LH; Cancer 2016 Oct 3
Schuetze SM; Bolejack V; Choy E; Ganjoo KN; Staddon AP; Chow WA; Tawbi HA; Samuels BL; Patel SR; von Mehren M; D'Amato G; Leu KM; Loeb DM; Forscher CA; Milhem MM; Rushing DA; Lucas DR; Chugh R; Reinke DK; Baker LH; Cancer 2016 Oct 3
Clinical benefit of a precision medicine based approach for guiding treatment of refractory cancers.
Radovich M; Kiel PJ; Nance SM; Niland EE; Parsley ME; Ferguson ME; Jiang G; Ammakkanavar NR; Einhorn LH; Cheng L; Nassiri M; Davidson DD; Rushing DA; Loehrer PJ; Pili R; Hanna N; Callaghan JT; Skaar TC; Helft PR; Shahda S; O'Neil BH; Schneider BP; Oncotarget 2016 Aug 30
Radovich M; Kiel PJ; Nance SM; Niland EE; Parsley ME; Ferguson ME; Jiang G; Ammakkanavar NR; Einhorn LH; Cheng L; Nassiri M; Davidson DD; Rushing DA; Loehrer PJ; Pili R; Hanna N; Callaghan JT; Skaar TC; Helft PR; Shahda S; O'Neil BH; Schneider BP; Oncotarget 2016 Aug 30
SARC009: Phase 2 study of dasatinib in patients with previously treated, high-grade, advanced sarcoma.
Schuetze SM; Wathen JK; Lucas DR; Choy E; Samuels BL; Staddon AP; Ganjoo KN; von Mehren M; Chow WA; Loeb DM; Tawbi HA; Rushing DA; Patel SR; Thomas DG; Chugh R; Reinke DK; Baker LH; Cancer 2015 Dec 28
Schuetze SM; Wathen JK; Lucas DR; Choy E; Samuels BL; Staddon AP; Ganjoo KN; von Mehren M; Chow WA; Loeb DM; Tawbi HA; Rushing DA; Patel SR; Thomas DG; Chugh R; Reinke DK; Baker LH; Cancer 2015 Dec 28
American Board of Internal Medicine - Hospice and Palliative Medicine
Pain Medicine
Oncology
American Board of Internal Medicine - Internal Medicine
Sarcoma; palliative care; pain management
Looking for patient care?
To schedule an appointment with a faculty member physician of IU School of Medicine, contact Indiana University Health at 888-484-3258 or use the physician finder by clicking the button below.